138 related articles for article (PubMed ID: 37429447)
1. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
[TBL] [Abstract][Full Text] [Related]
2. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
[TBL] [Abstract][Full Text] [Related]
4. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y
EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction.
Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875
[TBL] [Abstract][Full Text] [Related]
6. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
Nicolas J; Beerkens F; Cao D; Sartori S; Pivato CA; Qiu H; Giustino G; Chiarito M; Claessen BE; Zhang Z; Nardin M; Razuk V; Jones D; Camaj A; Power D; Banashefski B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
J Thromb Thrombolysis; 2022 Jan; 53(1):20-29. PubMed ID: 34347202
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
[TBL] [Abstract][Full Text] [Related]
8. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
[TBL] [Abstract][Full Text] [Related]
9. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
[TBL] [Abstract][Full Text] [Related]
11. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
[TBL] [Abstract][Full Text] [Related]
12. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3.
Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
[TBL] [Abstract][Full Text] [Related]
13. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
[TBL] [Abstract][Full Text] [Related]
14. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ
BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318
[TBL] [Abstract][Full Text] [Related]
15. Simplified Academic Research Consortium for High Bleeding Risk (ARC-HBR) Definition Predicts Bleeding Events in Patients With Heart Failure.
Sato Y; Yoshihisa A; Takeishi R; Ohara H; Sugawara Y; Ichijo Y; Hotsuki Y; Watanabe K; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Nakazato K; Takeishi Y
Circ J; 2021 Dec; 86(1):147-155. PubMed ID: 34707066
[TBL] [Abstract][Full Text] [Related]
16. Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis.
Montalto C; Munafò AR; Arzuffi L; Casula M; Mandurino-Mirizzi A; Costa F; Leonardi S; Oltrona Visconti L; Ferlini M
Hellenic J Cardiol; 2022; 66():59-66. PubMed ID: 35550178
[TBL] [Abstract][Full Text] [Related]
17. Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition.
Gragnano F; Spirito A; Corpataux N; Vaisnora L; Galea R; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Bär S; Ueki Y; Capodanno D; Urban P; Pocock SJ; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
EuroIntervention; 2021 Dec; 17(11):e898-e909. PubMed ID: 34105513
[TBL] [Abstract][Full Text] [Related]
18. Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
Int J Cardiol; 2021 Feb; 325():121-126. PubMed ID: 33053391
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions.
Tomoi Y; Kuramitsu S; Shinozaki T; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
EuroIntervention; 2023 Apr; 18(16):e1368-e1377. PubMed ID: 36579610
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Escaned J; Cao D; Baber U; Nicolas J; Sartori S; Zhang Z; Dangas G; Angiolillo DJ; Briguori C; Cohen DJ; Collier T; Dudek D; Gibson M; Gil R; Huber K; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta S; Moliterno DJ; Ohman EM; Oldroyd KG; Sardella G; Sharma SK; Shlofmitz R; Weisz G; Witzenbichler B; Pocock S; Mehran R
Eur Heart J; 2021 Dec; 42(45):4624-4634. PubMed ID: 34662382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
